[The possible novel treatment of achondroplasia, C-type natriuretic peptide (CNP)]. 2003

Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine.

C-type natiruetic peptide (CNP) showed a potent effect on the elongation of the tibial organ culture system. CNP also corrected the dwarfing phenotype of the CNP knockout mice. These results suggest that CNP is the novel promoter of the endochondral ossification, and that CNP/GC-B activation is possible target of the treatment of the achondroplasia.

UI MeSH Term Description Entries

Related Publications

Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
April 1991, Science (New York, N.Y.),
Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
May 1993, Brain research,
Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
August 1991, Endocrinology,
Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
December 1994, Endocrinology,
Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
January 2016, Endocrine development,
Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
January 2010, Endocrine journal,
Yasato Komatsu, and Akihiro Yasoda, and Hideki Chusho, and Kazuwa Nakao
March 1997, Journal of neuroendocrinology,
Copied contents to your clipboard!